化合物CH5183284 T6024

Product Introduction
Bioactivity


英文名: Zoligratinib

描述: Zoligratinib (CH5183284) 是一种口服具有活力的，选择性的FGFR 抑制剂，能够抑制FGFR1 (IC50:9.3 nM)，FGFR2 (IC50:7.6 nM)，FGFR3 (IC50:22 nM)，FGFR4 (IC50:290 nM)。

细胞实验: The cell lines are added to the wells of 96-well plates containing 0.076 to 10,000 nM CH5183284/Debio 1347 and incubated at 37°C. After 4 days of incubation, Cell Counting Kit-8 solution is added and, after incubation for several more hours, absorbance at 450 nm is measured with the iMark Microplate-Reader. The antiproliferative activity is calculated using the formula (1 ? T/C) × 100 (%), where T and C represent absorbance at 450 nm of the cells treated with drugs (T) and that of untreated control cells (C). The IC50 values are calculated using Microsoft Excel 2007.(Only for Reference)

激酶实验: Protein kinase assay: The inhibitory activity of CH5183284/Debio 1347 against FGFR1 is evaluated using a radiometric filter assay by measuring the incorporation of 33Pi with a microplate scintillation counter. The phosphorylation activities of LCK, EGFR, KIT, MET, SRC, BRK, FGFR2, Flt3, LTK, INSR, YES, ABL, EPHA2, ZAP70, Fyn, IGF1R, KDR, and PDGFR on substrate peptides are determined by homogeneous time-resolved fluorescence assay with LANCE Eu-W1024 labeled anti-phosphotyrosine PT66 antibody according to standard methods. Time-resolved fluorescence is measured with an EnVision HTS microplate reader. The activities of Aurora A, Akt1/PKBα, PKA, Cdk1/cyclin B, Cdk2/cyclin A, PKCα, PKCβ1 and PKCβ2 on substrate peptides are determined by IMAP FP Screening Express Progressive Binding System. Fluorescence polarization is measured with an EnVision HTS microplate reader.

体外活性: In the DMS114 (FGFR1 amplification), SNU-16 (FGFR2 amplification), and KMS11 cell lines,CH5183284(100 to 300 nM) prevents autophosphorylation of FGFR1, FGFR2, and FGFR3.

存储条件: Powder: -20°C for 3 years | In solvent: -80°C for 1 year

溶解度: Ethanol : 1 mg/mL (2.8 mM)
DMSO : 66 mg/mL (185.2 mM)


关键字: Debio1347 | Fibroblast growth factor receptor | CH 5183284 | FF-284 | Inhibitor | Debio-1347 | inhibit | CH-5183284 | FGFR | Zoligratinib | FF 284

相关产品: TAK-632 | Futibatinib | EGFR-IN-16 | SM27 | Dovitinib lactate hydrate | PHA-680632 | S49076 HCl | SUN11602 | Brivanib | Lenvatinib

相关库: Drug Repurposing Compound Library | Anti-Cancer Drug Library | Membrane Protein-targeted Compound Library | Anti-Lung Cancer Compound Library | Anti-Cancer Clinical Compound Library | Kinase Inhibitor Library | Inhibitor Library | Tyrosine Kinase Inhibitor Library | Anti-Cancer Active Compound Library | Anti-Pancreatic Cancer Compound Library

化合物CH5183284 T6024信息由TargetMol中国为您提供，如您想了解更多关于化合物CH5183284 T6024报价、型号、参数等信息，欢迎来电或留言咨询。

注：该产品未在中华人民共和国食品药品监督管理部门申请医疗器械注册和备案，不可用于临床诊断或治疗等相关用途